Search
for
Sort by
Research 30 of 117
- RASopathic Skin Eruptions during Vemurafenib Therapy
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- Vemurafenib-induced pityriasis amiantacea: a case report
- Correction: RASopathic Skin Eruptions during Vemurafenib Therapy
- Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Cutaneous toxicities of new treatments for melanoma
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- 696 MEK and BRAF inhibitors augment the production and accumulation of sebum in hamster sebocytes
- Targeted therapy in melanoma
- Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K.
- Biological therapy in the treatment of melanoma
- 559 Visualization of sweat suppression following botulinum toxin A by soluble microneedle arrays
- 556 α 1 -AR agonist induced piloerection protects against the development of traction alopecia
- 557 A peptide derivative with known anti-wrinkle properties was identified as potent dipeptiylpeptidase-4 inhibitor
- Management of Toxicities of Targeted Therapies
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Skin Adipocyte Stem Cell Self-Renewal Is Regulated by a PDGFA/AKT-Signaling Axis
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- A novel mouse model demonstrates that oncogenic melanocyte stem cells engender melanoma resembling human disease
- Hair disorders in patients with cancer
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Anatomic location of primary melanoma: Survival differences and sun exposure
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Alopecia in Association with Malignancy: A Review
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology